Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Redsense Medical is a Swedish medical technology company specializing in patient safety solutions for hemodialysis. The company's core product, the Redsense system, is a monitoring device designed to detect Venous Needle Dislodgement (VND) and accidental blood loss by utilizing fiber-optic sensor technology. The system provides real-time alerts to caregivers or patients, significantly mitigating the risk of life-threatening hemorrhaging, particularly in home hemodialysis settings where patients may be unmonitored. Additionally, the company offers the Redsense Clamp, which integrates with the alarm system to automatically stop blood flow upon leak detection. Headquartered in Sweden, Redsense Medical is publicly traded and maintains a strong commercial focus on the United States and European markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Redsense Medical.